Lyell Immunopharma logo

Lyell Immunopharma

A biotechnology company developing cellular immunotherapies for treating cancer.

2

Funding Rounds

$179.0m

Money raised

Overview

A biotechnology company developing cellular immunotherapies for treating cancer.

Funding

Funding series

Funding Series Analysis

The company Lyell Immunopharma has raised a total of $179m in funding over 2 rounds.

Key Insights:

  • Lyell Immunopharma funding round, February 2019: $179m
Lyell Immunopharma logo
Lyell Immunopharma funding round, February 2019 $179m